Vitestro transform patient care with autonomous blood drawing technology.
Vitestro has raised $70.0M in total funding. The most recent round was Series B. The last funding was announced in March 2026.
Vitestro's investors include Invest-NL, Mayo Clinic, Sonder Capital, European Innovation Council, European Innovation Council Fund.
Vitestro is headquartered in Utrecht, The Netherlands.
Vitestro transform patient care with autonomous blood drawing technology.
Vitestro is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Vitestro — Funding & Investors." VCBacked, March 10, 2026, https://www.vcbacked.co/company/vitestro. Accessed September 14, 2026.
VCBacked. (2026). Vitestro — Funding & Investors. Retrieved September 14, 2026, from https://www.vcbacked.co/company/vitestro
{{cite web |title=Vitestro — Funding & Investors |url=https://www.vcbacked.co/company/vitestro |website=VCBacked |access-date=September 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated